Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30002551
Basic Information
VIS ID
TVIS30002551
Fusion event
HIV-NFAT5 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr16
Cytoband
q22.1
Reference genome
GRCh37/hg19
Start
69603510/69569607 (Hg38)
End
69603510/69569607 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA16B
Target gene
NFAT5
miRNAs that regulate target gene
hsa-mir-31-5p
;
hsa-mir-24-3p
;
hsa-mir-335-5p
;
hsa-mir-21-5p
;
hsa-mir-877-5p
;
hsa-mir-652-3p
;
hsa-mir-17-5p
;
hsa-mir-211-5p
;
hsa-mir-30a-5p
;
hsa-mir-30c-5p
;
hsa-mir-30d-5p
;
hsa-mir-30b-5p
;
hsa-mir-30e-5p
;
hsa-mir-4690-5p
;
hsa-mir-20a-5p
;
hsa-mir-93-5p
;
hsa-mir-103a-2-5p
;
hsa-mir-106a-5p
;
hsa-mir-106b-5p
;
hsa-mir-20b-5p
;
hsa-mir-519c-3p
;
hsa-mir-526b-3p
;
hsa-mir-519b-3p
;
hsa-mir-519d-3p
;
hsa-mir-519a-3p
;
hsa-mir-580-5p
;
hsa-mir-651-3p
;
hsa-mir-889-3p
;
hsa-mir-1252-5p
;
hsa-mir-4476
;
hsa-mir-5692c
;
hsa-mir-5692b
;
hsa-mir-6815-3p
;
hsa-mir-6826-5p
;
hsa-mir-6876-5p
;
hsa-mir-3910
;
hsa-mir-548an
;
hsa-mir-1468-3p
;
hsa-mir-548p
;
hsa-mir-921
;
hsa-mir-3174
;
hsa-mir-3609
;
hsa-mir-548ah-5p
;
hsa-mir-6507-3p
;
hsa-mir-4796-3p
;
hsa-mir-374a-5p
;
hsa-mir-155-5p
;
hsa-mir-7111-5p
;
hsa-mir-6883-5p
;
hsa-mir-6825-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-6797-5p
;
hsa-mir-1249-5p
;
hsa-mir-650
;
hsa-mir-3612
;
hsa-mir-766-5p
;
hsa-mir-6133
;
hsa-mir-6130
;
hsa-mir-6129
;
hsa-mir-6127
;
hsa-mir-4510
;
hsa-mir-1827
;
hsa-mir-4419a
;
hsa-mir-5681a
;
hsa-mir-205-5p
;
hsa-mir-4536-5p
;
hsa-mir-6770-5p
;
hsa-mir-6073
;
hsa-mir-1253
;
hsa-mir-552-3p
;
hsa-mir-6768-5p
;
hsa-mir-6505-5p
;
hsa-mir-6844
;
hsa-mir-9-5p
;
hsa-mir-1-3p
;
hsa-mir-206
;
hsa-mir-613
;
hsa-mir-6124
;
hsa-mir-3175
;
hsa-mir-8085
;
hsa-mir-6731-5p
;
hsa-mir-6878-5p
;
hsa-mir-3202
;
hsa-mir-4756-5p
;
hsa-mir-3179
;
hsa-mir-4739
;
hsa-mir-1321
;
hsa-mir-6760-5p
;
hsa-mir-6873-5p
;
hsa-mir-4797-3p
;
hsa-mir-6512-5p
;
hsa-mir-3941
;
hsa-mir-4789-3p
;
hsa-mir-603
;
hsa-mir-362-3p
;
hsa-mir-329-3p
;
hsa-mir-8485
;
hsa-mir-4261
;
hsa-mir-4496
;
hsa-mir-146a-5p
;
hsa-mir-3180-5p
;
hsa-mir-345-5p
;
hsa-mir-4256
;
hsa-mir-4706
;
hsa-mir-4749-5p
;
hsa-mir-4762-3p
;
hsa-mir-520a-5p
;
hsa-mir-525-5p
;
hsa-mir-6731-3p
;
hsa-mir-744-5p
;
hsa-mir-1273h-5p
;
hsa-mir-17-3p
;
hsa-mir-30b-3p
;
hsa-mir-3160-3p
;
hsa-mir-3192-5p
;
hsa-mir-3689a-3p
;
hsa-mir-3689b-3p
;
hsa-mir-3689c
;
hsa-mir-3689d
;
hsa-mir-4311
;
hsa-mir-4443
;
hsa-mir-4487
;
hsa-mir-485-5p
;
hsa-mir-490-3p
;
hsa-mir-558
;
hsa-mir-6134
;
hsa-mir-6499-3p
;
hsa-mir-6779-5p
;
hsa-mir-6780a-5p
;
hsa-mir-6799-5p
;
hsa-mir-6851-5p
;
hsa-mir-6880-5p
;
hsa-mir-6884-5p
;
hsa-mir-7106-5p
;
hsa-mir-7847-3p
;
hsa-mir-7851-3p
Nearest miRNA
hsa-mir-1225/Upstream/3739; hsa-mir-11401/Downstream/363474;
Nearest TSS
ENST00000527434/Upstream/3256;
ENST00000563474/Downstream/77525;
Nearest CpG islands
None/Target,
chr16-CpG: 29/Upstream/2774
,
chr16-CpG: 19/Downstream/156783
Upstream sequence
agtccgggatagtggggggcaagtgggttttgtagttgagcttaaatttgaataccaacttagctccttattagttctgtgacttcgggcaagtgatttt
Downstream sequence
acctctctaaactttaatattcttcctgttaaaatgtagctgtctcttaaatttagtgagctaatgtgtattaaattgcctagcatagcgtctagcttaa
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate